Faes Farma SA
FAE
ISIN ES0134950F36 / Valor 2837976
Faes Farma SA
UMushroom community rating:
About company
Faes Farma SA is a pharmaceutical company based in Leioa, Spain, with additional offices and subsidiaries in various countries around the world. The company is primarily focused on the research, development, manufacturing, and marketing of prescription medicines, healthcare products, and animal nutrition products. Faes Farma SA is actively engaged in the pharmaceutical industry, producing a range of products to meet the needs of healthcare professionals and consumers globally.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (16.10.2025):
Faes Farma SA reported positive financial performance in the latest quarter of 2025, showcasing growth in its pharmaceutical business and strategic advancements in the ophthalmology sector.
Pharmaceutical Business Growth
The pharmaceutical division saw a 9% increase, reaching €269 million. International markets contributed significantly with a 14% growth, while licenses grew by 13%, driven by the success of key molecules such as Bilastine, Calcifediol, and Mesalazine.
Strategic Acquisitions
Faes Farma strengthened its position in the ophthalmology market through strategic acquisitions, including the recent purchase of Edol in March. These moves have expanded the company's portfolio and facilitated direct entry into new European markets.
Dividend Distribution
The company approved a final dividend payment of €0.138 per share on July 7, culminating in a total dividend of €0.179 per share with a payout ratio of 51%, reflecting shareholder support and confidence in Faes Farma's strategic direction.
Ophthalmology Expansion
Ophthalmology remains a key growth area for Faes Farma, with expectations of double-digit growth. This focus aligns with the company's global strategy and enhances its international expansion efforts.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
1617 M
Market cap (USD)
172,856
Daily traded volume (Shares)
3.47 / 3.405
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
